These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8239769)

  • 1. Reinfection in paediatric Lyme borreliosis.
    Rose CD; Fawcett PT; Klein JD; Eppes SC; Caputo GM; Doughty RA
    Ann Rheum Dis; 1993 Sep; 52(9):695-6. PubMed ID: 8239769
    [No Abstract]   [Full Text] [Related]  

  • 2. Complications of Lyme borreliosis.
    Cooke WD; Dattwyler RJ
    Annu Rev Med; 1992; 43():93-103. PubMed ID: 1580609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lyme disease in clinical practice.
    Płusa T; Ligezińska B; Zabielski S; Raczka A
    Pneumonol Alergol Pol; 1992; 60 Suppl 1():71-5. PubMed ID: 1292852
    [No Abstract]   [Full Text] [Related]  

  • 4. Cutaneous manifestations of Lyme borreliosis.
    Berger BW
    Rheum Dis Clin North Am; 1989 Nov; 15(4):627-34. PubMed ID: 2685922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current perspective on Lyme borreliosis.
    Kaslow RA
    JAMA; 1992 Mar; 267(10):1381-3. PubMed ID: 1740862
    [No Abstract]   [Full Text] [Related]  

  • 6. Procalcitonin levels in patients with Lyme borreliosis.
    Lotric-Furlan S; Maraspin-Carman V; Cimperman J; Ogrinc K; Stopar T; Strle F
    Wien Klin Wochenschr; 2002 Jul; 114(13-14):530-2. PubMed ID: 12422595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased IgA rheumatoid factor and V(H)1 associated cross reactive idiotype expression in patients with Lyme arthritis and neuroborreliosis.
    Axford JS; Rees DH; Mageed RA; Wordsworth P; Alavi A; Steere AC
    Ann Rheum Dis; 1999 Dec; 58(12):757-61. PubMed ID: 10577962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Skin manifestations of Lyme borreliosis].
    Nammous AH; Zubacki D; Dobrzycki I
    Przegl Lek; 2006; 63(4):227-30. PubMed ID: 17080746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lyme borreliosis.
    Scarpa C; Trevisan G; Stinco G
    Dermatol Clin; 1994 Oct; 12(4):669-85. PubMed ID: 7805296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Reinfection in Lyme borreliosis].
    Grygorczuk S; Pancewicz S; Zajkowska J; Kondrusik M; Swierzbińska R; Moniuszko A; Pawlak-Zalewska W
    Pol Merkur Lekarski; 2008 Sep; 25(147):257-9. PubMed ID: 19112844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of test with antigen VlsE (C6) with tests with recombinant antigens in patients with Lyme borreliosis].
    Zajkowska JM; Kondrusik M; Pancewicz SA; Grygorczuk S; Jamiołkowski J; Stalewska J
    Pol Merkur Lekarski; 2007 Aug; 23(134):95-9. PubMed ID: 18044336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nodular fasciitis, erythema migrans, and oligoarthritis: manifestations of Lyme borreliosis caused by Borrelia afzelii.
    Schnarr S; Wahl A; Jürgens-Saathoff B; Mengel M; Kreipe HH; Zeidler H
    Scand J Rheumatol; 2002; 31(3):184-6. PubMed ID: 12195636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiological survey of human borreliosis diagnosed in Eastern Slovakia.
    Stefancíková A; Pet'ko B; Rozická I; Salyová N; Ohlasová D
    Ann Agric Environ Med; 2001; 8(2):171-5. PubMed ID: 11748874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No association with HLA class II alleles in Swedish patients with cutaneous manifestations of Lyme borreliosis.
    Olsson I; Asbrink E; Olerup O
    Acta Derm Venereol; 1994 Jul; 74(4):262-5. PubMed ID: 7976082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphoproliferative responses to Borrelia burgdorferi in patients with erythema migrans, acrodermatitis chronica atrophicans, lymphadenosis benigna cutis, and morphea.
    Buechner SA; Lautenschlager S; Itin P; Bircher A; Erb P
    Arch Dermatol; 1995 Jun; 131(6):673-7. PubMed ID: 7778918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of the 3M FASTLYME IgG/IgM test in diagnosing skin manifestations of Borreliosis (preliminary remarks)].
    Fiedorowicz J; Szamer B
    Pneumonol Alergol Pol; 1994; 62 Suppl 2():70-1. PubMed ID: 7894373
    [No Abstract]   [Full Text] [Related]  

  • 17. Diagnosis, treatment, and prognosis of erythema migrans and Lyme arthritis.
    Feder HM; Abeles M; Bernstein M; Whitaker-Worth D; Grant-Kels JM
    Clin Dermatol; 2006; 24(6):509-20. PubMed ID: 17113969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comments on the course and classification of Lyme borreliosis.
    Asbrink E; Hovmark A
    Scand J Infect Dis Suppl; 1991; 77():41-3. PubMed ID: 1947810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunity to Lyme disease: protection, pathology and persistence.
    Seiler KP; Weis JJ
    Curr Opin Immunol; 1996 Aug; 8(4):503-9. PubMed ID: 8794009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Skin manifestations in Lyme borreliosis. 3: Erythema migrans].
    Hassler D
    Fortschr Med; 1997 Oct; 115(30):44-5. PubMed ID: 9453942
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.